Home/Abera Bioscience/Maria Alriksson
MA

Maria Alriksson

CEO

Abera Bioscience

Therapeutic Areas

Abera Bioscience Pipeline

DrugIndicationPhase
Nasal Pneumococcal VaccinePneumococcal disease (serotype-independent)Pre-clinical
Nasal Influenza VaccineInfluenzaPre-clinical